HSD47 Treatment Response, Healthcare Resource Use, and Economic Outcomes Associated With Tumor Necrosis Factor Inhibitor Cycling Versus Switching to an Advanced Therapy With Different Mechanism of Action in Rheumatoid Arthritis

Abstract

Open access

Peer reviewed

M Bergman, P M Zueger, Y Peng and R Thielen

Value in health, v 27(6), pp S229-S229

Jun 2024

Files and links (1)

url

https://doi.org/10.1016/j.jval.2024.03.1270View

Published, Version of Record (VoR) Open

10 Record Views

Title: HSD47 Treatment Response, Healthcare Resource Use, and Economic Outcomes Associated With Tumor Necrosis Factor Inhibitor Cycling Versus Switching to an Advanced Therapy With Different Mechanism of Action in Rheumatoid Arthritis
Creators: M Bergman - Drexel University
P M Zueger - AbbVie, North Chicago, IL, USA
Y Peng - AbbVie Inc, Maple Grove, MN, USA
R Thielen - AbbVie, North Chicago, IL, USA
Publication Details: Value in health, v 27(6), pp S229-S229
Publisher: Elsevier
Resource Type: Abstract
Language: English
Academic Unit: Medicine (Graduate)
Other Identifier: 991021916904304721